The sensitivity and specificity for IgM to distinguish the COVID-19 patients and non- COVID-19 patients was 87.04% (95% CI, 83.77–90.31%) and 96.92% (95% CI, 95.19–98.64%), respectively. The gene discussed is CD40LG; the disease is COVID-19.